SDC1 and blood coagulation disease: We determined our cut-off level of ≥30.5 ng/mL as the level of syndecan-1 for prediction of early coagulopathy as the outcome (area under the curve = 0.62; 95% Confidence interval (CI) 0.50 to 0.72) (Figure 3).